loading

Finanzdaten der Akari Therapeutics Plc Adr-Aktie (AKTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
3.525
- - - -
Operating Income/Loss
33.21%
-3.525
-5.278 -2.927 -7.449 -5.989
Nonoperating Income/Loss
111.95%
-0.18
1.506 0.032 -0.109 0.423
Income/Loss From Continuing Operations Before Tax
1.78%
-3.705
-3.772 -2.895 -7.558 -5.566
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
1.78%
-3.705
-3.772 -2.895 -7.558 -5.566
Net Income/Loss
1.78%
-3.705
-3.772 -2.895 -7.558 -5.566
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
997.01%
54,588.28
4,976.08 24,386.01 18,836.48 13,453.15
Diluted Average Shares
997.01%
54,588.28
4,976.08 24,386.01 18,836.48 13,453.15
Basic Earnings Per Share
-
- - - -
Diluted Earnings Per Share
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$98.21
price down icon 1.73%
$100.38
price down icon 2.91%
$32.85
price down icon 4.45%
$116.14
price down icon 2.77%
$157.64
price down icon 2.89%
biotechnology ONC
$348.67
price up icon 3.86%
Kapitalisierung:     |  Volumen (24h):